• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)].

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):617-623. doi: 10.3760/cma.j.issn.0253-2727.2020.08.001.

DOI:10.3760/cma.j.issn.0253-2727.2020.08.001
PMID:32942813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7525165/
Abstract
摘要

相似文献

1
[Chinese guideline on the diagnosis and management of adult primary immune thrombocytopenia (version 2020)].《成人原发性免疫性血小板减少症诊断与治疗中国指南（2020年版）》
Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):617-623. doi: 10.3760/cma.j.issn.0253-2727.2020.08.001.
2
[Adapted guideline for the diagnosis and treatment of primary immune thrombocytopenia for Chinese children (2021)].《中国儿童原发性免疫性血小板减少症诊疗指南（2021年版）》
Zhonghua Er Ke Za Zhi. 2021 Oct 2;59(10):810-819. doi: 10.3760/cma.j.cn112140-20210509-00397.
3
[Consensus of Chinese experts on diagnosis and treatment of adult primary immune thrombocytopenia (version 2012)].《成人原发免疫性血小板减少症诊断与治疗中国专家共识（2012年版）》
Zhonghua Xue Ye Xue Za Zhi. 2012 Nov;33(11):975-7.
4
[Chinese expert consensus on the diagnosis and treatment of thromboembolism in patients with immune thrombocytopenia (2023)].《免疫性血小板减少症患者血栓栓塞症诊断与治疗中国专家共识（2023年版）》
Zhonghua Xue Ye Xue Za Zhi. 2023 Jan 14;44(1):6-11. doi: 10.3760/cma.j.issn.0253-2727.2023.01.002.
5
[Recommendation in the diagnosis and treatment of adult primary immune thrombocytopenia].[成人原发性免疫性血小板减少症的诊断与治疗推荐]
Zhonghua Nei Ke Za Zhi. 2021 Jun 1;60(6):501-505. doi: 10.3760/cma.j.cn112138-20200714-00670.
6
[Recommendations for diagnosis and treatment of primary immune thrombocytopenia in children].[儿童原发性免疫性血小板减少症的诊断与治疗建议]
Zhonghua Er Ke Za Zhi. 2013 May;51(5):382-4.
7
2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy.《2021年妊娠合并原发性免疫性血小板减少症诊断与管理中国专家共识》
Chin Med J (Engl). 2022 Apr 20;135(8):887-889. doi: 10.1097/CM9.0000000000002043.
8
[To standardize the diagnosis and treatment of primary immune thrombocytopenia in children].[规范儿童原发性免疫性血小板减少症的诊断与治疗]
Zhonghua Er Ke Za Zhi. 2021 Oct 2;59(10):807-809. doi: 10.3760/cma.j.cn112140-20210814-00669.
9
[Intensive reading of Recommendations for Diagnosis and Treatment of Primary Immune Thrombocytopenia in Children].[儿童原发性免疫性血小板减少症诊断与治疗建议精读]
Zhonghua Er Ke Za Zhi. 2013 May;51(5):389-91.
10
[Thrombocytopenia].[血小板减少症]
Rev Prat. 2005 Jun 30;55(12):1355-61.

引用本文的文献

1
Low-dose rituximab followed by mycophenolate mofetil for steroid-dependent/frequently relapsing nephrotic syndrome in children: a case series.低剂量利妥昔单抗联合霉酚酸酯治疗儿童激素依赖型/频繁复发型肾病综合征：病例系列
Front Pharmacol. 2025 Aug 26;16:1646837. doi: 10.3389/fphar.2025.1646837. eCollection 2025.
2
Dose-optimised recombinant human thrombopoietin eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study).剂量优化的重组人血小板生成素艾曲泊帕治疗免疫性血小板减少症患者：一项多中心随机对照试验（TE-ITP研究）
EClinicalMedicine. 2025 Aug 21;87:103459. doi: 10.1016/j.eclinm.2025.103459. eCollection 2025 Sep.
3

本文引用的文献

1
A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia.免疫性血小板减少症中糖蛋白特异性直接血小板自身抗体检测的现代重新评估
Blood Adv. 2020 Jan 14;4(1):9-18. doi: 10.1182/bloodadvances.2019000868.
2
American Society of Hematology 2019 guidelines for immune thrombocytopenia.美国血液学会 2019 年免疫性血小板减少症治疗指南。
Blood Adv. 2019 Dec 10;3(23):3829-3866. doi: 10.1182/bloodadvances.2019000966.
3
Updated international consensus report on the investigation and management of primary immune thrombocytopenia.
Natural killer cell granule protein 7 contributes to CD8 T cell-mediated platelet apoptosis in immune thrombocytopenia.
自然杀伤细胞颗粒蛋白7在免疫性血小板减少症中促进CD8 T细胞介导的血小板凋亡。
Res Pract Thromb Haemost. 2025 Jul 22;9(5):102977. doi: 10.1016/j.rpth.2025.102977. eCollection 2025 Jul.
4
Comparative analysis of MAIPA assay and PakAuto assay for the diagnosis of primary immune thrombocytopenia.用于原发性免疫性血小板减少症诊断的单克隆抗体免疫固定血小板抗原检测法（MAIPA法）与PakAuto检测法的对比分析
Clin Exp Med. 2025 Aug 7;25(1):282. doi: 10.1007/s10238-025-01831-8.
5
Real-world experience of hetrombopag in immune thrombocytopenia treatment: a retrospective cohort study.艾曲泊帕治疗免疫性血小板减少症的真实世界经验：一项回顾性队列研究。
Eur J Med Res. 2025 Jul 5;30(1):574. doi: 10.1186/s40001-025-02850-7.
6
Immunotherapy-associated hemostatic abnormalities: bleeding and thrombotic complications.免疫治疗相关的止血异常：出血和血栓形成并发症。
Ann Hematol. 2025 Jul;104(7):3537-3551. doi: 10.1007/s00277-025-06482-z. Epub 2025 Jul 1.
7
Clinical characteristic of isolated thrombocytopenia in patients with bone marrow failure-related germline variants: a retrospective study from a single centre.骨髓衰竭相关种系变异患者孤立性血小板减少症的临床特征：一项单中心回顾性研究
Ann Med. 2025 Dec;57(1):2523560. doi: 10.1080/07853890.2025.2523560. Epub 2025 Jun 26.
8
Efficacy and safety of a new 10% intravenous immunoglobulin (IVIG) in Chinese patients with primary immune thrombocytopenia (ITP): a multicenter, single-arm, phase III trial.一种新型10%静脉注射免疫球蛋白（IVIG）在中国原发性免疫性血小板减少症（ITP）患者中的疗效和安全性：一项多中心、单臂、III期试验。
Clin Exp Med. 2025 May 12;25(1):153. doi: 10.1007/s10238-025-01658-3.
9
A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory Immune Thrombocytopenia.泽布替尼治疗复发/难治性免疫性血小板减少症的病例系列及文献综述
Cancer Rep (Hoboken). 2025 Feb;8(2):e70152. doi: 10.1002/cnr2.70152.
10
Refractory immune thrombocytopenia treated with low-dose decitabine combined with recombinant human thrombopoietin or eltrombopag: Two case reports.低剂量地西他滨联合重组人血小板生成素或艾曲泊帕治疗难治性免疫性血小板减少症：两例病例报告
Medicine (Baltimore). 2025 Feb 7;104(6):e41449. doi: 10.1097/MD.0000000000041449.
更新的原发性免疫性血小板减少症的调查和管理国际共识报告。
Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.
4
A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia.一项关于低剂量地西他滨治疗成人难治性免疫性血小板减少症的前瞻性、多中心研究。
Am J Hematol. 2019 Dec;94(12):1374-1381. doi: 10.1002/ajh.25646. Epub 2019 Oct 17.
5
ACOG Practice Bulletin No. 207 Summary: Thrombocytopenia in Pregnancy.ACOG 实践公告第 207 号总结：妊娠血小板减少症。
Obstet Gynecol. 2019 Mar;133(3):589-591. doi: 10.1097/AOG.0000000000003101.
6
Chinese guidelines for treatment of adult primary immune thrombocytopenia.成人原发性免疫性血小板减少症中国治疗指南。
Int J Hematol. 2018 Jun;107(6):615-623. doi: 10.1007/s12185-018-2445-z. Epub 2018 Apr 4.
7
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.依曲泊帕治疗慢性/持续性 ITP 的长期安全性和疗效：EXTEND 研究的最终结果。
Blood. 2017 Dec 7;130(23):2527-2536. doi: 10.1182/blood-2017-04-748707. Epub 2017 Oct 17.
8
Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.口服全反式维甲酸联合达那唑与达那唑作为成人原发性免疫性血小板减少症二线治疗的比较：一项多中心、随机、开放标签的2期试验。
Lancet Haematol. 2017 Oct;4(10):e487-e496. doi: 10.1016/S2352-3026(17)30170-9. Epub 2017 Sep 13.
9
Long-term outcomes of laparoscopic versus open splenectomy for immune thrombocytopenia.腹腔镜与开放性脾切除术治疗免疫性血小板减少症的长期疗效
Surg Today. 2018 Feb;48(2):180-185. doi: 10.1007/s00595-017-1570-2. Epub 2017 Jul 19.
10
A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy.一种新型重组人血小板生成素治疗妊娠免疫性血小板减少症。
Blood. 2017 Aug 31;130(9):1097-1103. doi: 10.1182/blood-2017-01-761262. Epub 2017 Jun 19.